1. Home
  2. GORO vs ATNM Comparison

GORO vs ATNM Comparison

Compare GORO & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$0.73

Market Cap

112.3M

ML Signal

HOLD

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

HOLD

Current Price

$1.40

Market Cap

50.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
ATNM
Founded
1998
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.3M
50.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GORO
ATNM
Price
$0.73
$1.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$1.38
$4.00
AVG Volume (30 Days)
1.1M
194.8K
Earning Date
11-04-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
$90,000.00
Revenue This Year
$8.76
N/A
Revenue Next Year
$85.95
$42,943.57
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.11
52 Week Low
$0.16
$1.03
52 Week High
$1.18
$2.41

Technical Indicators

Market Signals
Indicator
GORO
ATNM
Relative Strength Index (RSI) 50.66 51.02
Support Level $0.71 $1.33
Resistance Level $0.80 $1.54
Average True Range (ATR) 0.05 0.09
MACD 0.01 0.01
Stochastic Oscillator 55.23 56.90

Price Performance

Historical Comparison
GORO
ATNM

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Share on Social Networks: